Philip Reigan
Concepts (406)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ribosomal Protein S6 Kinases, 90-kDa | 5 | 2025 | 12 | 2.760 |
Why?
| | Protein Kinase Inhibitors | 11 | 2026 | 969 | 2.500 |
Why?
| | Thymidine Phosphorylase | 7 | 2022 | 14 | 2.220 |
Why?
| | Antineoplastic Agents | 17 | 2025 | 2194 | 2.210 |
Why?
| | Pyrimidines | 7 | 2026 | 532 | 1.750 |
Why?
| | Protein-Tyrosine Kinases | 6 | 2019 | 433 | 1.480 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2025 | 190 | 1.350 |
Why?
| | Cell Cycle Proteins | 5 | 2018 | 628 | 1.280 |
Why?
| | Nuclear Proteins | 6 | 2018 | 748 | 1.260 |
Why?
| | Enzyme Inhibitors | 9 | 2021 | 824 | 1.150 |
Why?
| | Neoplasms | 6 | 2025 | 2875 | 1.090 |
Why?
| | Models, Molecular | 26 | 2025 | 1618 | 1.040 |
Why?
| | STAT3 Transcription Factor | 3 | 2022 | 207 | 1.010 |
Why?
| | Glioblastoma | 3 | 2022 | 353 | 0.980 |
Why?
| | Pyrazoles | 4 | 2018 | 509 | 0.870 |
Why?
| | Pyrroles | 2 | 2021 | 217 | 0.820 |
Why?
| | Small Molecule Libraries | 3 | 2025 | 111 | 0.770 |
Why?
| | Prodrugs | 4 | 2007 | 52 | 0.730 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 8 | 2011 | 34 | 0.700 |
Why?
| | Drug Resistance, Neoplasm | 5 | 2025 | 881 | 0.690 |
Why?
| | Pyrimidinones | 4 | 2018 | 126 | 0.680 |
Why?
| | Protein Isoforms | 2 | 2025 | 402 | 0.660 |
Why?
| | Purines | 1 | 2021 | 187 | 0.630 |
Why?
| | Pteridines | 1 | 2020 | 22 | 0.620 |
Why?
| | Cell Survival | 8 | 2022 | 1098 | 0.600 |
Why?
| | Structure-Activity Relationship | 10 | 2020 | 570 | 0.590 |
Why?
| | Indolequinones | 5 | 2011 | 5 | 0.570 |
Why?
| | Aldehydes | 8 | 2014 | 142 | 0.530 |
Why?
| | HSP90 Heat-Shock Proteins | 5 | 2011 | 47 | 0.530 |
Why?
| | Protein Binding | 12 | 2021 | 2273 | 0.490 |
Why?
| | Cell Line, Tumor | 19 | 2026 | 3540 | 0.490 |
Why?
| | Glutamate-Cysteine Ligase | 2 | 2013 | 20 | 0.480 |
Why?
| | Medulloblastoma | 2 | 2016 | 215 | 0.480 |
Why?
| | Xanthine Oxidase | 2 | 2007 | 79 | 0.470 |
Why?
| | Brain Neoplasms | 3 | 2020 | 1318 | 0.460 |
Why?
| | Benzoquinones | 4 | 2011 | 47 | 0.460 |
Why?
| | Uracil | 3 | 2021 | 36 | 0.440 |
Why?
| | Isoxazoles | 5 | 2023 | 53 | 0.430 |
Why?
| | Polycomb Repressive Complex 1 | 2 | 2026 | 66 | 0.420 |
Why?
| | Molecular Dynamics Simulation | 4 | 2025 | 259 | 0.410 |
Why?
| | Hydroquinones | 3 | 2011 | 29 | 0.410 |
Why?
| | Cisplatin | 1 | 2016 | 334 | 0.400 |
Why?
| | Lactams, Macrocyclic | 3 | 2011 | 51 | 0.400 |
Why?
| | Deoxyribose | 1 | 2013 | 6 | 0.400 |
Why?
| | Molecular Docking Simulation | 7 | 2026 | 124 | 0.380 |
Why?
| | Drug Screening Assays, Antitumor | 5 | 2020 | 191 | 0.380 |
Why?
| | Glutathione | 2 | 2011 | 375 | 0.370 |
Why?
| | Humans | 61 | 2026 | 144759 | 0.370 |
Why?
| | Molecular Structure | 5 | 2020 | 499 | 0.340 |
Why?
| | Cell Proliferation | 11 | 2026 | 2496 | 0.320 |
Why?
| | Catalytic Domain | 5 | 2021 | 232 | 0.300 |
Why?
| | Protein Conformation | 4 | 2021 | 946 | 0.300 |
Why?
| | Cell Line | 5 | 2022 | 2882 | 0.290 |
Why?
| | Aldehyde Dehydrogenase | 3 | 2014 | 99 | 0.280 |
Why?
| | Glucose | 2 | 2013 | 1047 | 0.280 |
Why?
| | Imidazoles | 3 | 2021 | 254 | 0.280 |
Why?
| | Animals | 31 | 2026 | 38058 | 0.280 |
Why?
| | Molecular Targeted Therapy | 3 | 2016 | 432 | 0.270 |
Why?
| | Proto-Oncogene Proteins B-raf | 2 | 2021 | 225 | 0.270 |
Why?
| | Amides | 2 | 2020 | 101 | 0.260 |
Why?
| | Growth Inhibitors | 1 | 2007 | 39 | 0.260 |
Why?
| | Signal Transduction | 6 | 2022 | 5226 | 0.250 |
Why?
| | Proto-Oncogene Proteins c-akt | 4 | 2013 | 436 | 0.240 |
Why?
| | src Homology Domains | 2 | 2016 | 35 | 0.240 |
Why?
| | Aurora Kinase A | 1 | 2026 | 62 | 0.240 |
Why?
| | Thyroid Neoplasms | 2 | 2021 | 345 | 0.230 |
Why?
| | Azepines | 1 | 2026 | 107 | 0.230 |
Why?
| | Pancreatic Neoplasms | 4 | 2009 | 919 | 0.230 |
Why?
| | Butyrates | 1 | 2026 | 67 | 0.220 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2023 | 529 | 0.220 |
Why?
| | Binding Sites | 6 | 2018 | 1329 | 0.220 |
Why?
| | Rotenone | 1 | 2024 | 16 | 0.210 |
Why?
| | G-Quadruplexes | 2 | 2022 | 25 | 0.210 |
Why?
| | alpha-Synuclein | 1 | 2024 | 46 | 0.210 |
Why?
| | Giardia lamblia | 1 | 2024 | 23 | 0.200 |
Why?
| | Pyrrolidines | 1 | 2004 | 125 | 0.200 |
Why?
| | Dopaminergic Neurons | 1 | 2024 | 67 | 0.200 |
Why?
| | Thymidine | 2 | 2022 | 60 | 0.200 |
Why?
| | Mice | 20 | 2026 | 18339 | 0.190 |
Why?
| | Neuroprotective Agents | 1 | 2024 | 143 | 0.190 |
Why?
| | Rifabutin | 3 | 2008 | 7 | 0.190 |
Why?
| | Receptors, Glucocorticoid | 1 | 2024 | 138 | 0.190 |
Why?
| | DNA | 3 | 2016 | 1463 | 0.190 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2014 | 97 | 0.180 |
Why?
| | Tumor Microenvironment | 2 | 2025 | 732 | 0.180 |
Why?
| | Ear Diseases | 1 | 2022 | 18 | 0.180 |
Why?
| | Amino Acid Transport System ASC | 1 | 2022 | 12 | 0.180 |
Why?
| | Models, Chemical | 1 | 2023 | 269 | 0.180 |
Why?
| | K562 Cells | 2 | 2020 | 93 | 0.180 |
Why?
| | Virus Internalization | 1 | 2022 | 65 | 0.180 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2022 | 47 | 0.180 |
Why?
| | Catalysis | 3 | 2013 | 322 | 0.170 |
Why?
| | Drug Synergism | 3 | 2021 | 357 | 0.170 |
Why?
| | Quinone Reductases | 2 | 2011 | 17 | 0.170 |
Why?
| | Mice, Inbred C57BL | 6 | 2026 | 5992 | 0.170 |
Why?
| | Fluorouracil | 1 | 2022 | 235 | 0.170 |
Why?
| | Maneb | 1 | 2020 | 9 | 0.170 |
Why?
| | Receptors, Androgen | 1 | 2022 | 153 | 0.160 |
Why?
| | Heterocyclic Compounds | 1 | 2020 | 23 | 0.160 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 138 | 0.160 |
Why?
| | Lipoprotein Lipase | 1 | 2020 | 56 | 0.160 |
Why?
| | Polymorphism, Genetic | 2 | 2014 | 612 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2022 | 167 | 0.160 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2020 | 2027 | 0.160 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 175 | 0.160 |
Why?
| | Neovascularization, Pathologic | 1 | 2022 | 286 | 0.160 |
Why?
| | Intestinal Mucosa | 1 | 2026 | 676 | 0.160 |
Why?
| | Fluorescence | 1 | 2020 | 161 | 0.160 |
Why?
| | Amino Acid Sequence | 8 | 2014 | 2155 | 0.150 |
Why?
| | Adenocarcinoma, Follicular | 1 | 2019 | 41 | 0.140 |
Why?
| | Thyroid Carcinoma, Anaplastic | 1 | 2019 | 36 | 0.140 |
Why?
| | Enzyme Assays | 1 | 2018 | 25 | 0.140 |
Why?
| | Protein Carbonylation | 3 | 2013 | 57 | 0.140 |
Why?
| | CDC2 Protein Kinase | 1 | 2018 | 27 | 0.140 |
Why?
| | Chromatography, High Pressure Liquid | 5 | 2013 | 594 | 0.140 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2018 | 37 | 0.140 |
Why?
| | Pyridazines | 1 | 2018 | 57 | 0.140 |
Why?
| | Phosphorylation | 3 | 2018 | 1732 | 0.130 |
Why?
| | Neoplastic Stem Cells | 1 | 2022 | 412 | 0.130 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 253 | 0.130 |
Why?
| | Antigens, Neoplasm | 2 | 2011 | 271 | 0.130 |
Why?
| | Glucocorticoids | 1 | 2022 | 535 | 0.130 |
Why?
| | Dihydropyridines | 1 | 2017 | 15 | 0.130 |
Why?
| | Escherichia coli | 4 | 2006 | 854 | 0.130 |
Why?
| | Xenograft Model Antitumor Assays | 5 | 2026 | 928 | 0.130 |
Why?
| | Cyclic S-Oxides | 1 | 2016 | 1 | 0.130 |
Why?
| | Niclosamide | 1 | 2016 | 2 | 0.130 |
Why?
| | Glycoproteins | 2 | 2011 | 355 | 0.130 |
Why?
| | Fluorescence Polarization | 1 | 2016 | 24 | 0.130 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 210 | 0.130 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2022 | 682 | 0.120 |
Why?
| | Antioxidants | 2 | 2011 | 549 | 0.120 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2016 | 44 | 0.120 |
Why?
| | M Phase Cell Cycle Checkpoints | 1 | 2016 | 24 | 0.120 |
Why?
| | MicroRNAs | 1 | 2023 | 701 | 0.120 |
Why?
| | Lysine | 2 | 2023 | 302 | 0.120 |
Why?
| | Molecular Sequence Data | 7 | 2014 | 2930 | 0.120 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2013 | 143 | 0.120 |
Why?
| | Quantitative Structure-Activity Relationship | 1 | 2015 | 20 | 0.120 |
Why?
| | Antiviral Agents | 1 | 2022 | 767 | 0.120 |
Why?
| | Immunity, Innate | 1 | 2022 | 846 | 0.120 |
Why?
| | Crystallography, X-Ray | 5 | 2017 | 492 | 0.110 |
Why?
| | Cells, Cultured | 3 | 2020 | 4154 | 0.110 |
Why?
| | Small-Conductance Calcium-Activated Potassium Channels | 1 | 2015 | 13 | 0.110 |
Why?
| | Drug Design | 1 | 2016 | 173 | 0.110 |
Why?
| | Oxidation-Reduction | 5 | 2020 | 1087 | 0.110 |
Why?
| | Retinaldehyde | 1 | 2014 | 4 | 0.110 |
Why?
| | Allosteric Regulation | 3 | 2023 | 98 | 0.110 |
Why?
| | HeLa Cells | 1 | 2016 | 650 | 0.110 |
Why?
| | Acetaldehyde | 1 | 2014 | 17 | 0.110 |
Why?
| | Sulfhydryl Compounds | 2 | 2020 | 189 | 0.110 |
Why?
| | Drug Discovery | 1 | 2016 | 155 | 0.110 |
Why?
| | Recombinant Proteins | 5 | 2011 | 1370 | 0.110 |
Why?
| | Mass Spectrometry | 4 | 2012 | 750 | 0.110 |
Why?
| | Membrane Proteins | 2 | 2011 | 1166 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 851 | 0.110 |
Why?
| | Alzheimer Disease | 1 | 2020 | 621 | 0.100 |
Why?
| | Parkinson Disease | 1 | 2020 | 600 | 0.100 |
Why?
| | DNA Repair | 1 | 2016 | 256 | 0.100 |
Why?
| | Pituitary Neoplasms | 1 | 2015 | 190 | 0.100 |
Why?
| | Computer Simulation | 4 | 2014 | 1025 | 0.100 |
Why?
| | Fatty Liver, Alcoholic | 1 | 2013 | 14 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 138 | 0.100 |
Why?
| | Mammary Glands, Animal | 2 | 2011 | 128 | 0.100 |
Why?
| | Protein Folding | 2 | 2014 | 279 | 0.100 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 120 | 0.100 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 162 | 0.100 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 1 | 2013 | 24 | 0.100 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2013 | 105 | 0.100 |
Why?
| | Lactation | 2 | 2011 | 192 | 0.100 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2014 | 167 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 331 | 0.090 |
Why?
| | Cell Cycle | 2 | 2014 | 596 | 0.090 |
Why?
| | Gout | 1 | 2013 | 35 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2013 | 2608 | 0.090 |
Why?
| | Inflammation | 2 | 2022 | 2878 | 0.090 |
Why?
| | Apoptosis | 6 | 2021 | 2430 | 0.090 |
Why?
| | Electron Transport Complex I | 1 | 2012 | 42 | 0.090 |
Why?
| | PTEN Phosphohydrolase | 1 | 2013 | 164 | 0.090 |
Why?
| | Glutathione Reductase | 1 | 2011 | 25 | 0.090 |
Why?
| | Acridines | 1 | 2011 | 9 | 0.090 |
Why?
| | Glutathione Peroxidase | 1 | 2011 | 39 | 0.090 |
Why?
| | Status Epilepticus | 1 | 2012 | 56 | 0.090 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2012 | 79 | 0.090 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2011 | 47 | 0.090 |
Why?
| | Glutathione Transferase | 1 | 2011 | 100 | 0.090 |
Why?
| | Flavoproteins | 1 | 2011 | 8 | 0.090 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 209 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1953 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 459 | 0.080 |
Why?
| | Transcriptional Activation | 1 | 2013 | 383 | 0.080 |
Why?
| | Mitochondria, Liver | 1 | 2011 | 70 | 0.080 |
Why?
| | Organelles | 1 | 2011 | 57 | 0.080 |
Why?
| | Glycolipids | 1 | 2011 | 52 | 0.080 |
Why?
| | Myocytes, Cardiac | 1 | 2015 | 556 | 0.080 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 336 | 0.080 |
Why?
| | Sirtuin 3 | 1 | 2011 | 60 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2013 | 766 | 0.080 |
Why?
| | Milk | 1 | 2011 | 119 | 0.080 |
Why?
| | Superoxide Dismutase | 1 | 2012 | 301 | 0.080 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2011 | 141 | 0.080 |
Why?
| | Kinetics | 1 | 2013 | 1627 | 0.080 |
Why?
| | Protein Processing, Post-Translational | 1 | 2012 | 477 | 0.080 |
Why?
| | Brain | 2 | 2012 | 2933 | 0.080 |
Why?
| | Phospholipids | 1 | 2011 | 213 | 0.070 |
Why?
| | Cell Movement | 1 | 2014 | 965 | 0.070 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2009 | 14 | 0.070 |
Why?
| | Histone Deacetylase Inhibitors | 2 | 2026 | 220 | 0.070 |
Why?
| | Oxidative Stress | 2 | 2014 | 1339 | 0.070 |
Why?
| | Adenosine Triphosphate | 1 | 2011 | 498 | 0.070 |
Why?
| | Peroxiredoxin VI | 1 | 2008 | 9 | 0.070 |
Why?
| | Tumor Cells, Cultured | 3 | 2022 | 919 | 0.070 |
Why?
| | Protein Structure, Tertiary | 4 | 2014 | 862 | 0.070 |
Why?
| | Indoles | 2 | 2015 | 501 | 0.070 |
Why?
| | Breast Neoplasms | 2 | 2020 | 2452 | 0.070 |
Why?
| | Down-Regulation | 1 | 2011 | 627 | 0.070 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2012 | 370 | 0.070 |
Why?
| | Disease Models, Animal | 4 | 2024 | 4557 | 0.070 |
Why?
| | Protein Interaction Domains and Motifs | 3 | 2013 | 148 | 0.070 |
Why?
| | Quinones | 1 | 2007 | 8 | 0.070 |
Why?
| | Cross-Linking Reagents | 1 | 2008 | 207 | 0.070 |
Why?
| | DNA-Binding Proteins | 2 | 2013 | 1499 | 0.070 |
Why?
| | Spectrophotometry, Infrared | 1 | 2007 | 55 | 0.070 |
Why?
| | Lipid Metabolism | 1 | 2011 | 527 | 0.070 |
Why?
| | Mutation | 4 | 2021 | 4089 | 0.060 |
Why?
| | Acrolein | 1 | 2007 | 22 | 0.060 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2007 | 22 | 0.060 |
Why?
| | Cell Membrane | 1 | 2011 | 706 | 0.060 |
Why?
| | Galactosides | 1 | 2006 | 9 | 0.060 |
Why?
| | beta-Galactosidase | 1 | 2006 | 77 | 0.060 |
Why?
| | Energy Metabolism | 1 | 2012 | 935 | 0.060 |
Why?
| | Substrate Specificity | 3 | 2014 | 388 | 0.060 |
Why?
| | Dextran Sulfate | 1 | 2026 | 92 | 0.060 |
Why?
| | Anti-Bacterial Agents | 2 | 2024 | 1907 | 0.060 |
Why?
| | Arginine | 3 | 2013 | 262 | 0.060 |
Why?
| | Carcinoma | 1 | 2007 | 228 | 0.060 |
Why?
| | RNA, Messenger | 2 | 2024 | 2832 | 0.060 |
Why?
| | Nitroimidazoles | 1 | 2005 | 16 | 0.060 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2011 | 179 | 0.050 |
Why?
| | Biological Availability | 1 | 2005 | 142 | 0.050 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2007 | 630 | 0.050 |
Why?
| | Phenanthrenes | 1 | 2024 | 12 | 0.050 |
Why?
| | Emetine | 1 | 2024 | 7 | 0.050 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 2 | 2014 | 23 | 0.050 |
Why?
| | Parkinsonian Disorders | 1 | 2024 | 43 | 0.050 |
Why?
| | Substantia Nigra | 1 | 2024 | 63 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2026 | 297 | 0.050 |
Why?
| | Computational Biology | 1 | 2008 | 680 | 0.050 |
Why?
| | Mice, Nude | 2 | 2021 | 682 | 0.050 |
Why?
| | Colon | 1 | 2026 | 304 | 0.050 |
Why?
| | Polycomb-Group Proteins | 1 | 2023 | 36 | 0.050 |
Why?
| | Wound Healing | 1 | 2026 | 351 | 0.050 |
Why?
| | Colitis | 1 | 2026 | 280 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2024 | 222 | 0.050 |
Why?
| | Exoribonucleases | 1 | 2023 | 45 | 0.050 |
Why?
| | Benzamides | 1 | 2023 | 224 | 0.050 |
Why?
| | Insulin Resistance | 1 | 2011 | 1241 | 0.050 |
Why?
| | Ribosomes | 1 | 2024 | 191 | 0.050 |
Why?
| | Peptides | 2 | 2023 | 995 | 0.050 |
Why?
| | Alcohols | 1 | 2022 | 28 | 0.050 |
Why?
| | Molecular Conformation | 2 | 2015 | 148 | 0.050 |
Why?
| | Phospholipase C beta | 1 | 2022 | 30 | 0.050 |
Why?
| | Mesocricetus | 1 | 2022 | 46 | 0.050 |
Why?
| | Hep G2 Cells | 2 | 2013 | 74 | 0.040 |
Why?
| | Stress, Physiological | 2 | 2015 | 453 | 0.040 |
Why?
| | Ear | 1 | 2022 | 31 | 0.040 |
Why?
| | Peptide Mapping | 2 | 2012 | 63 | 0.040 |
Why?
| | Ethanol | 3 | 2012 | 627 | 0.040 |
Why?
| | Stem Cells | 1 | 2026 | 626 | 0.040 |
Why?
| | Sequence Alignment | 2 | 2012 | 366 | 0.040 |
Why?
| | Oximes | 1 | 2021 | 26 | 0.040 |
Why?
| | Perilipin-2 | 2 | 2011 | 40 | 0.040 |
Why?
| | Serine Endopeptidases | 1 | 2022 | 128 | 0.040 |
Why?
| | Neural Crest | 1 | 2022 | 126 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2023 | 175 | 0.040 |
Why?
| | Angiogenesis Inhibitors | 1 | 2003 | 237 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 130 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2022 | 210 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 80 | 0.040 |
Why?
| | Cell-Free System | 2 | 2011 | 53 | 0.040 |
Why?
| | Female | 9 | 2026 | 78271 | 0.040 |
Why?
| | Blotting, Western | 2 | 2013 | 1187 | 0.040 |
Why?
| | HEK293 Cells | 2 | 2013 | 744 | 0.040 |
Why?
| | Viral Load | 1 | 2022 | 526 | 0.040 |
Why?
| | Lipoproteins | 1 | 2020 | 169 | 0.040 |
Why?
| | Carbon | 1 | 2020 | 203 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2006 | 1519 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 310 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2007 | 1982 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2019 | 251 | 0.030 |
Why?
| | Triglycerides | 1 | 2020 | 520 | 0.030 |
Why?
| | Piperazines | 1 | 2021 | 381 | 0.030 |
Why?
| | Microglia | 1 | 2020 | 268 | 0.030 |
Why?
| | Amyloid beta-Peptides | 1 | 2020 | 241 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2026 | 2050 | 0.030 |
Why?
| | Genomics | 2 | 2014 | 834 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 2 | 2013 | 576 | 0.030 |
Why?
| | Drug Resistance, Multiple | 1 | 2017 | 25 | 0.030 |
Why?
| | Male | 7 | 2024 | 72315 | 0.030 |
Why?
| | Dimerization | 1 | 2017 | 194 | 0.030 |
Why?
| | Child | 1 | 2016 | 22633 | 0.030 |
Why?
| | Models, Biological | 2 | 2014 | 1821 | 0.030 |
Why?
| | Nitroglycerin | 1 | 2014 | 14 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2012 | 2527 | 0.030 |
Why?
| | Circular Dichroism | 1 | 2015 | 150 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2014 | 85 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 60 | 0.030 |
Why?
| | Calorimetry | 1 | 2014 | 72 | 0.030 |
Why?
| | Magnesium | 1 | 2014 | 155 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 3162 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2014 | 396 | 0.020 |
Why?
| | Cell Cycle Checkpoints | 1 | 2013 | 99 | 0.020 |
Why?
| | Retinoid X Receptors | 1 | 2013 | 38 | 0.020 |
Why?
| | Caco-2 Cells | 1 | 2013 | 79 | 0.020 |
Why?
| | Lung | 2 | 2022 | 4109 | 0.020 |
Why?
| | RNA Splice Sites | 1 | 2013 | 50 | 0.020 |
Why?
| | Hyperuricemia | 1 | 2013 | 47 | 0.020 |
Why?
| | Adult | 1 | 2016 | 40449 | 0.020 |
Why?
| | Macrophages | 1 | 2020 | 1511 | 0.020 |
Why?
| | Kainic Acid | 1 | 2012 | 33 | 0.020 |
Why?
| | Biotinylation | 1 | 2012 | 37 | 0.020 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2012 | 42 | 0.020 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2012 | 10 | 0.020 |
Why?
| | Synaptosomes | 1 | 2012 | 32 | 0.020 |
Why?
| | Methyltransferases | 1 | 2013 | 74 | 0.020 |
Why?
| | Anura | 1 | 2012 | 45 | 0.020 |
Why?
| | Electron Transport Complex IV | 1 | 2012 | 62 | 0.020 |
Why?
| | Fishes | 1 | 2013 | 108 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 110 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2013 | 118 | 0.020 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2012 | 50 | 0.020 |
Why?
| | Molecular Weight | 1 | 2012 | 327 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2012 | 151 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 266 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2012 | 116 | 0.020 |
Why?
| | Rats | 2 | 2012 | 5597 | 0.020 |
Why?
| | Ubiquitination | 1 | 2012 | 118 | 0.020 |
Why?
| | Oxidants | 1 | 2012 | 103 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2011 | 91 | 0.020 |
Why?
| | Amination | 1 | 2011 | 2 | 0.020 |
Why?
| | Sulfonamides | 1 | 2015 | 580 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2015 | 726 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 346 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1716 | 0.020 |
Why?
| | Alkylation | 1 | 2011 | 27 | 0.020 |
Why?
| | Telomere | 1 | 2015 | 288 | 0.020 |
Why?
| | Protein Subunits | 1 | 2012 | 226 | 0.020 |
Why?
| | Genome, Human | 1 | 2014 | 422 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2012 | 232 | 0.020 |
Why?
| | Lipid Droplets | 1 | 2011 | 21 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2013 | 454 | 0.020 |
Why?
| | Binding, Competitive | 1 | 2011 | 193 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2012 | 540 | 0.020 |
Why?
| | DNA Primers | 1 | 2012 | 512 | 0.020 |
Why?
| | Metabolic Networks and Pathways | 1 | 2012 | 187 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2011 | 72 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2011 | 81 | 0.020 |
Why?
| | Ligands | 1 | 2013 | 673 | 0.020 |
Why?
| | Mammary Glands, Human | 1 | 2011 | 67 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2011 | 160 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2011 | 75 | 0.020 |
Why?
| | NAD | 1 | 2011 | 81 | 0.020 |
Why?
| | Mammals | 1 | 2012 | 293 | 0.020 |
Why?
| | Acetylation | 1 | 2011 | 252 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 983 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 369 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 940 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 380 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1047 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1306 | 0.020 |
Why?
| | DNA Breaks, Single-Stranded | 1 | 2009 | 5 | 0.020 |
Why?
| | Animal Feed | 1 | 2008 | 53 | 0.020 |
Why?
| | NADPH-Ferrihemoprotein Reductase | 1 | 2008 | 10 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 2012 | 514 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2008 | 85 | 0.020 |
Why?
| | Phylogeny | 1 | 2012 | 1016 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2013 | 1257 | 0.020 |
Why?
| | Hypoxia | 1 | 2015 | 1199 | 0.020 |
Why?
| | Caspases | 1 | 2009 | 232 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2014 | 1455 | 0.020 |
Why?
| | Tetrazolium Salts | 1 | 2006 | 18 | 0.020 |
Why?
| | Transcription Factor AP-1 | 1 | 2007 | 79 | 0.020 |
Why?
| | NFATC Transcription Factors | 1 | 2007 | 93 | 0.020 |
Why?
| | Oxygen | 1 | 2012 | 995 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2006 | 106 | 0.020 |
Why?
| | Deoxyuridine | 1 | 2006 | 6 | 0.010 |
Why?
| | Cell Respiration | 1 | 2006 | 107 | 0.010 |
Why?
| | Thiazoles | 1 | 2006 | 135 | 0.010 |
Why?
| | Cysteine | 1 | 2007 | 210 | 0.010 |
Why?
| | Smoke | 1 | 2007 | 148 | 0.010 |
Why?
| | Superoxides | 1 | 2006 | 204 | 0.010 |
Why?
| | Drug Carriers | 1 | 2006 | 130 | 0.010 |
Why?
| | Mitochondria | 1 | 2012 | 984 | 0.010 |
Why?
| | Liver Neoplasms | 1 | 2012 | 780 | 0.010 |
Why?
| | Proteomics | 1 | 2012 | 1195 | 0.010 |
Why?
| | Drug Interactions | 1 | 2006 | 398 | 0.010 |
Why?
| | Colonic Neoplasms | 1 | 2006 | 259 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2006 | 724 | 0.010 |
Why?
| | Drug Delivery Systems | 1 | 2006 | 380 | 0.010 |
Why?
| | Respiratory Tract Infections | 1 | 2007 | 397 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 7173 | 0.010 |
Why?
| | Liver | 1 | 2008 | 1887 | 0.010 |
Why?
| | Cytokines | 1 | 2007 | 2061 | 0.010 |
Why?
| | Child, Preschool | 1 | 2014 | 11787 | 0.010 |
Why?
| | Aged | 1 | 2019 | 25913 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 35875 | 0.010 |
Why?
|
|
Reigan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|